inducement awards

Pacira BioSciences granted inducement equity awards to 10 new employees, including stock options and RSUs valued at approximately $1.5M, under Nasdaq rules.

AEON Biopharma appoints John Bencich as CFO with 754,717 RSUs and 235,849 PSUs. Company developing ABP-450 biosimilar targeting $3B neurotoxin market.

Kura Oncology granted 153,750 stock options at $8.34/share to six new employees under Nasdaq Rule 5635(c)(4), valued at approximately $1.28 million, with standard four-year vesting.

NBHC grants 13,867 performance share units to Vista Bank executives post-acquisition, with vesting tied to cumulative EPS and relative asset return metrics through April 2029.

EyePoint grants stock options to six new employees as clinical program advances toward Phase 3 topline data for wet AMD therapy.

Pacira BioSciences awarded stock options and RSUs to three new employees totaling 7,900 shares at $22.10 exercise price under its inducement plan.

Aardvark Therapeutics granted 152,338 stock options to six new hires with exercise prices of $13.48-$12.67, vesting over four years with a one-year cliff.